The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions July 27, 2012
MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder September 8, 2011
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer January 3, 2011
The safety and efficacy of ±3,4-methylenedioxymethamphetamineassisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder July 19, 2010
The correlation between ketamine and posttraumatic stress disorder in burned service members February 22, 2008
Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members July 27, 2007
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder November 11, 2006
